Breadcrumb News
Regional Perspective
HOME UK UK WORLD BUSINESS POLITICS CONFLICT ENVIRONMENT LIFESTYLE CULTURE SPORT OTHER
UK
BUSINESS POLITICS CONFLICT ENVIRONMENT LIFESTYLE CULTURE SPORT OTHER
AGENDAS LATEST
These reports, summaries, and scores are produced using AI and are provided 'as is.' They may contain errors or inaccuracies and should not be relied upon as definitive.
Agenda Signals / Health / Psychedelic Drugs

Psychedelic Drugs

Date Range
to
Score Range
to
NBC News : FDA grants quick review for 3 psychedelic drug trials
-4
− 0 +
-4

Downplaying the risks of psychedelic drugs by contrasting noribogaine with more intense psychedelics

[balanced_reporting] (severity 10/10): The article notes that noribogaine does not induce the 'intense, hours-long and sometimes emotionally upsetting high' of ibogaine, reducing perceived danger.

“Noribogaine reportedly does not induce the intense, hours-long and sometimes emotionally upsetting high associated with ibogaine.”

BUSINESS

  • Economy
  • Markets
  • Business
  • Tech

POLITICS

  • Foreign Policy
  • Domestic Policy
  • Economic Policy
  • Laws
  • Elections

CONFLICT

  • Europe
  • Middle East
  • Africa
  • Asia
  • North America
  • Latin America
  • Oceania

ENVIRONMENT

  • Natural Disasters
  • Weather
  • Renewables
  • Climate Change

LIFESTYLE

  • Fashion
  • Food & Drink
  • Health
  • Travel
  • Religion

CULTURE

  • Film & TV
  • Music
  • Social Media
  • Books & Radio
  • Art & Design

SPORT

  • Soccer
  • Cricket
  • Rugby
  • Basketball
  • Baseball
  • American Football
  • Tennis
  • Golf
  • Hockey

OTHER

  • Crime

REGIONS

  • UK
  • US
  • Ireland
  • Australia
  • New Zealand
  • Canada
  • World

AGENDAS

SITE

  • Home
  • Latest
  • Search
  • About
  • Preferences

© 2026 Breadcrumb News Limited. All rights reserved.